Probo Medical Completes Acquisition of National Ultrasound

Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced the acquisition of National Ultrasound, Inc. (“National”). Terms of the transaction were not disclosed.

National was founded in 2003 in Duluth, GA and has grown to be one of the largest ultrasound marketing and sales organizations in the country. National has been recognized in the Inc. 5000 list of fastest growing companies for seven consecutive years. Their team brings over 250 years of combined experience working with major ultrasound OEM’s. Over recent years, National has established themselves as a premier provider of ultrasound sales and support to veterinary practices across the country.

“National has a deep history for their sales and marketing prowess, selling new and pre-owned ultrasound equipment to private practices across the country,” said Michael Asmer, CEO of Probo. “They have leveraged that position to expand into the veterinary market.  The opportunity to connect this expertise to our world-class ultrasound sales, service, and repair services is tremendously exciting.”

“National has been a business built on relationships: with our employees, customers and OEM partners.  We found the same values in Probo as we were looking for a partner that could support, and even accelerate, our growth.  The depth, breadth and value proposition of Probo’s offering in ultrasound is second to none and we are excited to share that with our customers,” said Joe Williams, CEO of National.

Probo Medical is backed by Avista Capital Partners, a leading New York-based private equity firm with more than 40 growth-oriented healthcare businesses globally.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version